Thailand's Public Health Ministry has signed a Memorandum of Understanding  (MOU) with RxLeaf World Medica on establishing the International Medical Cannabis Research Centre.

The centre aims to be a knowledge hub for genetic research on medical cannabis, bringing together doctors, researchers, experts from Canada, the Netherlands and other countries to conduct cannabis products research and development while at the same time exchanging the medical cannabis knowledge.

Anutin Charnvirakul, Deputy Prime Minister of Thailand and Minister of Public Health, said the ministry has been promoting medical cannabis and its safe treatment. According to the study, cannabis can treat various diseases such as cancer, epilepsy, multiple sclerosis with muscle pain, and neuralgia.

The centre is one of the catalysts to support the economic recovery. This also conforms to the Thai government's plans to promote the country as a comprehensive medical hub in Asia, and to encourage the development of the cannabis value chain, including product cultivation, standardization, market expansion and support for investments in new products.